Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.
Actavis Inc has recalled a small batch of Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vials. The issue involves a labeling error where the carton and kit are labeled as containing 11.25 mg, but the actual vial inside is labeled as 3.75 mg. This discrepancy could lead to incorrect medication administration. Read more at govinfonow.com/recall/46375-actavis-inc-recalls-trelstar-triptorelin-pamoate-for-injectable-suspension-single.
“Actavis Recalls Trelstar Due to Labeling Error.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46375-actavis-inc-recalls-trelstar-triptorelin-pamoate-for-injectable-suspension-single. Based on FDA recall #D-1085-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1085-2014%22&limit=1).
Actavis Inc recalled Trelstar Injectable Suspension due to a labeling error where cartons declared as 11.25 mg contained vials labeled as 3.75 mg, the FDA said on Dec. 9, 2013.
How to tell if you have it
Brand: Actavis
Product: Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial plus MIXJECT Single-Dose Delivery System
NDC: 52544-154-02 and 52544-188-76
Lot #: 13J081
Expiration: 05/15
Quantity: 99 cartons
The hazard
The recall involves a labeling error on the declared strength. Trelstar 11.25 mg labeled cartons contained a vial labeled as 3.75 mg instead of one labeled as 11.25 mg.
Context
GovInfoNow's records show Actavis Inc has 13 other recalls on record since March 22, 2013. Other recent recalls include Actavis Levofloxacin Eye Drops (Feb. 7, 2017), Actavis Glipizide 2.5mg Tablets (Jan. 30, 2017), and Actavis Albuterol Inhaler (Jan. 12, 2017). Other recent recalls of similar products include Slate Run Eptifibatide Injection (Feb. 12, 2026), Fagron Tropicamide Eye Drops (Nov. 20, 2025), and Safecor Atomoxetine Capsules (April 30, 2026).
How to tell if you have this one
Check if you have Trelstar (triptorelin pamoate) for Injectable Suspension Single-Dose Vial with NDC 52544-154-02. Specifically, look for Lot # 13J081 with an expiration date of 05/15. The product is distributed by Watson Pharma, Inc., and includes a MIXJECT Single-Dose Delivery System.
Brand
Actavis
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using the Product
Do not use or administer any vials from Lot # 13J081 due to the labeling error regarding the drug strength.
Contact Your Provider
Reach out to your healthcare provider or pharmacist immediately to discuss alternative treatment options and verify if you possess the recalled lot.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1085-2014 (December 9, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1085-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.